Completed Access to Information Requests

Follow:

  • RSS
  • Cite
About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA). For additional information, please see the “About Access to Information Requests” webpage.

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 399 record(s)

Req # A-2016-001311

The following documents: the Health Canada reviewer reports for RITUXAN SC related to review of Clinical, Clinical Pharmacology and Chemistry & Manufacturing information; and the Risk Management Plan (RMP) for RITUXAN SC.

Organization: Health Canada

572 page(s)
August 2023

Req # A-2018-000914

Information on adverse events related to medical devices. Hyaluronic acid or botulinum based products as of 2018-10-04. From 2015 - 2017.

Organization: Health Canada

3333 page(s)
August 2023

Req # A-2018-001093

All information related to Natural Product Number (NPN) 80088599 provided, used and sent to and from Health Canada.

Organization: Health Canada

657 page(s)
August 2023

Req # A-2020-001730

A list of adverse reports that have resulted in deaths, regarding caffeinated energy drinks, taken from the consumption incident reports that have been received from Temporary Marketing Authorization Letter (TMAL) holders, in 2012, 2013 and 2016, as well as any other reports that resulted in death, within the incident reports that Health Canada has received since 2016.

Organization: Health Canada

1 page(s)
August 2023

Req # A-2021-000697

The briefing binder prepared for the head of the Canadian Drug Agency Transition Office. March 1, 2021 - April 30, 2021.

Organization: Health Canada

1200 page(s)
August 2023

Req # A-2021-001289

All Task & Solutions Professional Services (TSPS) and Task Based Informatics Professional Services (TBIPS) Supply Arrangement (SA) contracts and Standing Offer (SO) callups issued in the National Capital Region for the months of January 2021 to September 2021.

Organization: Health Canada

569 page(s)
August 2023

Req # A-2021-001290

All ProServices contracts issued in the National Capital Region for the months of January 2021 to September 2021.

Organization: Health Canada

1253 page(s)
August 2023

Req # A-2021-002048

Copies of Natural Product Number (NPN) Product Licence Application (PLA) application as well as all correspondence, review documents, notes and discussions relating to NPN 80106548.

Organization: Health Canada

221 page(s)
August 2023

Req # A-2022-000268

Regarding this announcement: https://www.canada.ca/en/health-canada/news/2022/05/government-of-canada-strengthens-access-to-abortion-services.html "National Abortion Federation (NAF) Canada will receive $1,469,150 in funding over three years, to provide financial and logistical support to women seeking abortion services, train health care providers in providing abortion services, and ensure abortion facilities have the capacity to continue to provide services and related care." All records internal to Health Canada, all records to and from any external government departments and the Prime Minister's Office (PMO), and all records to and from NAF, which led to the decision to grant this funding to NAF Canada.

Organization: Health Canada

604 page(s)
August 2023

Req # A-2022-000452

According to the Health Canada Generic Submissions Under Review List (updated June 22, 2022), Health Canada is currently reviewing an Abbreviated New Drug Submission (ANDS) seeking approval of a product containing the medicinal ingredient desmopressin acetate. The month and year that the Desmopressin ANDS was accepted into review and the status of the Desmopressin ANDS review.

Organization: Health Canada

1 page(s)
August 2023
Date modified: